article thumbnail

Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP

DAIC

Fadi Mansour performed the first Canadian implant of BIOTRONIK ’s newest pacemaker and CRT-P generation earlier this year at the Centre Hospitalier de l'Université de Montréal. The patient received an Amvia Sky HF-T QP triple chamber pacemaker device. Enhanced Closed Loop Stimulation (CLS) rate adaptation technology.

Pacemaker 105
article thumbnail

UC San Diego Health First in Region to Implant Dual Chamber, Leadless Pacemaker

DAIC

UC San Diego Health is the first in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with abnormal heart rhythms. Holding the device and pictured above is Ulrika Birgersdotter-Green, MD, cardiologist and director of pacemaker and ICD services at UC San Diego Health.

Pacemaker 105
article thumbnail

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

DAIC

milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. Orchestra BioMed and Medtronic, Inc.

Pacemaker 105
article thumbnail

Emerging pacemaker technology for small children

HeartRhythm

Devices and implantation techniques are primarily designed for the adult population. Pediatric electrophysiologists continue to find creative solutions to adapt adult-sized equipment into vulnerable pediatric patients.

article thumbnail

Post-mortem examination of a dual chamber leadless pacemaker system: implications for chronic atrial leadless pacemaker removal

HeartRhythm

The availability of dual chamber leadless pacemakers (LPs) expands the use of this technology for patients who need atrial pacing and reliable atrioventricular synchrony.1 1 Although the helix-fixation LPs are designed to be retrievable, only ventricular LPs have been removed in humans following extending dwell times.

article thumbnail

Heart rhythm in vitro: measuring stem cell-derived pacemaker cells on microelectrode arrays

Frontiers in Cardiovascular Medicine

However, there is currently no commercially available cell source to apply this technology in the context of the cardiac conduction system (CCS). In response to this problem, our group has previously developed a protocol for the generation of pure functional cardiac pacemaker cells from mouse embryonic stem cells (ESCs).

article thumbnail

ID: 4121951 Adoption Of Remote Monitoring-Supporting Technologies And Their Association With In-Person Visit Frequency

HeartRhythm

The 2023 HRS/EHRA/APHRS/LAHRS consensus statement on remote monitoring (RM) supports limiting scheduled in-person visits to every 24 months for patients with pacemakers and ICDs if consistent and continuous RM can be achieved.